Physician

Alaa Salah Eldin, MD

According to 2025 Medicare claims, Alaa Eldin, MD (NPI: 1548287386) practices gastroenterology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Hudson, NJ. Eldin uses personal NPI as billing NPI and primary practice location at 07094-2977.

Eldin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 237 traditional Medicare patients, billed 1,493 HCPCS/CPT codes, and received $119,933 in Medicare payments. The top billing code was 43239 (Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope). Part D data shows 4,695 prescription claims across 601 beneficiaries totaling $1,380,817 in drug costs, led by Linzess (Linaclotide). Open Payments data shows 6 records totaling $88. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $388,042 to $119,933. In contrast, Part D prescription costs have risen steadily, from $333,584 to $1,380,817. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	755	4,388	$388,042
2016	621	4,044	$335,699
2017	554	4,161	$318,539
2018	527	3,055	$254,212
2019	515	2,964	$242,960
2020	394	2,425	$193,053
2021	349	2,122	$178,957
2022	334	2,420	$201,306
2023	264	1,638	$139,665
2024	237	1,493	$119,933

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	378	2,909	$333,584
2016	372	3,240	$1,053,993
2017	327	2,680	$507,907
2018	330	1,970	$410,043
2019	364	2,360	$570,349
2020	332	2,575	$434,891
2021	417	3,880	$1,360,451
2022	485	4,188	$1,933,892
2023	607	4,675	$2,427,182
2024	601	4,695	$1,380,817

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	71	75	$106
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	85	109	$103
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	105	150	$101
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	83	132	$74
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	82	808	$62

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Linzess	Linaclotide	359	21,750	$380,858
Creon	Lipase/Protease/Amylase	198	7,211	$294,783
Lactulose	Lactulose	80	2,745	$202,406
Trulance	Plecanatide	93	4,260	$76,719
Jublia	Efinaconazole	11	510	$42,561

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$88	Ardelyx, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alaa Salah Eldin, MD?

Tedicare shows public-source Medicare data for Alaa Salah Eldin, MD (NPI 1548287386), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alaa Salah Eldin, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alaa Salah Eldin, MD?

A separate primary affiliated billing organization is not shown for this profile in the available data.

Does Alaa Salah Eldin, MD have Open Payments data?

Alaa Salah Eldin, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.